239,00 € – 379,00 €
This antibody reacts with the CD13-antigen, which is expressed on human monocytes, granulocytes and their precursors and a small population of large granular lymphocytes. The monoclonal antibody reacts with monocytes, granulocytes and with a large number of acute myeloid leukaemia’s (the positivity of this marker relates to worse clinic prognosis).
|Storage||Store in the dark at 2-8°C.|
CD13; LAP1; PEPN; gp150.
The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).
Human AML Cells.
Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.